Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2- phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists
José Luis Morales, Jacek Krzeminski, Shantu Amin, Gary H. Perdew
Dive into the research topics of 'Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2- phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists'. Together they form a unique fingerprint.